Search
Search Results
-
Long-term locoregional recurrence in patients treated for breast cancer
Background/PurposeLocoregional control in breast cancer is a fundamental part of treatment and determinant for survival outcomes. It has been...
-
Hepatocellular carcinoma: tumor heterogeneity and recurrence after preoperative locoregional therapy
How locoregional therapy (LRT) may change tumor compositional and functional heterogeneity, consequently contributing to treatment resistance and...
-
Locoregional Therapies for Treatment of Invasive Breast Cancer: Review of Contemporary Clinical Trials
Purpose of ReviewThis review highlights contemporary clinical trials of locoregional therapies in the treatment of invasive breast cancer, focusing...
-
3D-CEUS/MRI–CEUS fusion imaging vs 2D-CEUS after locoregional therapies for hepatocellular carcinoma: a multicenter prospective study of therapeutic response evaluation
ObjectivesTo compare the diagnostic accuracy of 3D contrast-enhanced ultrasound (CEUS)/MRI–CEUS fusion imaging with 2D-CEUS in assessing the response...
-
Genetic Considerations in the Locoregional Management of Breast Cancer: a Review of Current Evidence
Purpose of ReviewBreast cancer is the most commonly diagnosed cancer and is the second leading cause of cancer death in women. Breast cancer...
-
Locoregional Recurrence of Esophageal Cancer Treated with Curative Intent Local Salvage Therapy: A Single Center Experience
PurposeLocoregional recurrence of esophageal carcinoma after neoadjuvant therapy and en bloc esophagectomy, although uncommon, is challenging to...
-
Locoregional staging of breast cancer: contrast-enhanced mammography versus breast magnetic resonance imaging
PurposeBreast cancer diagnosis often involves assessing the locoregional spread of the disease through MRI, as multicentricity, multifocality and/or...
-
Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas
BackgroundRecurrence after curative-intent pancreatectomy for pancreatic ductal adenocarcinomas (PDAC) is quite frequent with locoregional and...
-
Salvage Locoregional Therapy Following Progression After Radiotherapy for Hepatocellular Carcinoma Is Associated with Improved Outcomes
PurposeTo evaluate the impact of salvage locoregional therapy (salvage-LT) on survival of hepatocellular carcinoma (HCC) patients presenting with...
-
Locoregional Management of Breast Cancer Following Neoadjuvant Chemotherapy
Purpose of ReviewThe treatment of breast cancer is evolving at accelerated rates. As systemic therapy continues to improve, the roles of surgery and...
-
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain
BackgroundThere are scarce data of the costs of non-small cell lung cancer (NSCLC) recurrence in Spain. The objective of this study is to assess the...
-
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
PurposeCaveolin-1 (CAV1) has been implicated in breast cancer oncogenesis and metastasis and may be a potential prognosticator, especially for...
-
Treatment patterns and survival of patients with locoregional recurrence in early-stage NSCLC: a literature review of real-world evidence
Approximately 10–50% of patients treated for early-stage (I–III), resectable non-small cell lung cancer (eNSCLC) will develop locoregional...
-
Trends in Locoregional Therapy in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer by Frailty and Life Expectancy
BackgroundIn women ≥ 70 years of age with T1N0 hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) breast...
-
Evaluation of the performance of and interobserver agreement on postoperative baseline CT findings in the identification of locoregional recurrence in patients with pancreatic ductal adenocarcinoma
PurposeTo evaluate interobserver agreement on the findings of baseline contrast-enhanced multidetector computed tomography (CE-MDCT) performed at the...
-
Estimating Risk of Locoregional Failure and Overall Survival in Anal Cancer Following Chemoradiation: A Machine Learning Approach
BackgroundOptimal treatment of anal squamous cell carcinoma (ASCC) is definitive chemoradiation. Patients with persistent or recurrent disease...
-
Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?
BackgroundThe level of C‑reactive protein (CRP) and alpha‑fetoprotein (AFP) in immunotherapy (CRAFITY) score was associated with the prognosis of...
-
MRI-based radiomics model and nomogram for predicting the outcome of locoregional treatment in patients with hepatocellular carcinoma
BackgroundPrediction of locoregional treatment response is important for further therapeutic strategy in patients with hepatocellular carcinoma. This...
-
Society of abdominal radiology survey of practice patterns in using LI-RADS treatment response criteria in the evaluation of hepatocellular carcinoma post-locoregional treatment
PurposeTo examine national trends in the adoption and use of the LI-RADS Treatment Response Algorithm.
MethodsMembers of the Society of Abdominal...
-
Prognostic value and mode selection of locoregional treatment in Stage-IV breast cancer patients
PurposeThis study aimed to assess the actual prognostic significance of different locoregional treatment (LRT) (surgery and radiotherapy) modalities...
